high ca125 control sera (Bio-Rad)
Structured Review

High Ca125 Control Sera, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 92/100, based on 19 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/high+ca125+control+sera/Liquichek+Tumor+Marker+Control/pmc11600309-181-16-23
Average 92 stars, based on 19 article reviews
Images
1) Product Images from "Improving Specificity for Ovarian Cancer Screening Using a Novel Extracellular Vesicle–Based Blood Test"
Article Title: Improving Specificity for Ovarian Cancer Screening Using a Novel Extracellular Vesicle–Based Blood Test
Journal: The Journal of Molecular Diagnostics : JMD
doi: 10.1016/j.jmoldx.2024.09.001
Figure Legend Snippet: OC Test and CA125 enzyme-linked immunosorbent assay performance in healthy controls and in ovarian cancers. A and C: Training study EDTA plasma samples are shown. B and D : The verification study serum samples are shown. The cutoff set between healthy controls and OC cases is shown as a red dotted line in each graph. HGSC, high-grade serous carcinoma; LGSC, low-grade serous carcinoma.
Techniques Used: Enzyme-linked Immunosorbent Assay, Clinical Proteomics
Figure Legend Snippet: Comparison of the Sensitivity of the OC Test and CA125 by Ovarian Cancer Histotype and Stage in the Verification Study
Techniques Used: Comparison
Figure Legend Snippet: OC Test and CA125 enzyme-linked immunosorbent assay performance in benign ovarian conditions. A and C: Training study EDTA plasma samples are shown. B and D: The verification study serum samples are shown. The cutoff set between healthy controls and OC cases is shown as a red dotted line in each graph.
Techniques Used: Enzyme-linked Immunosorbent Assay, Clinical Proteomics
Figure Legend Snippet: Comparison of the Performance of the OC Test and CA125 in Nonovarian Cancers and Inflammatory Conditions
Techniques Used: Comparison
Figure Legend Snippet: OC Test and CA125 enzyme-linked immunosorbent assay performance in nonovarian cancers and inflammatory conditions. A and C: Nonovarian (off-target cancer) samples are shown. B and D: The inflammatory condition samples are shown. The cutoff set between healthy controls and OC cases is shown as a red dotted line in each graph.
Techniques Used: Enzyme-linked Immunosorbent Assay
Figure Legend Snippet: Estimated Rates of False Positives due to Nonovarian Cancers if the OC Test or CA125 Was to Be Used for Screening an Average Risk Population
Techniques Used:
Related Articles
Clinical Proteomics:Article Title: Improving specificity for ovarian cancer screening using a novel extracellular vesicle-based blood test - Performance in a training and verification cohort. Article Snippet: The VarioSkan Lux (catalog number VL0000D0; Thermo Fisher Scientific, Waltham, MA) was used to measure the resultant OD of the plate at 450, 540, and 570 nm. .. Blinded human plasma and serum samples as well as Lyphochek Tumor Marker Plus low, medium, and Article Title: Improving Specificity for Ovarian Cancer Screening Using a Novel Extracellular Vesicle–Based Blood Test Article Snippet: The VarioSkan Lux (catalog number VL0000D0; Thermo Fisher Scientific, Waltham, MA) was used to measure the resultant OD of the plate at 450, 540, and 570 nm. .. Blinded human plasma and serum samples as well as Lyphochek Tumor Marker Plus low, medium, and Marker:Article Title: Improving specificity for ovarian cancer screening using a novel extracellular vesicle-based blood test - Performance in a training and verification cohort. Article Snippet: The VarioSkan Lux (catalog number VL0000D0; Thermo Fisher Scientific, Waltham, MA) was used to measure the resultant OD of the plate at 450, 540, and 570 nm. .. Blinded human plasma and serum samples as well as Lyphochek Tumor Marker Plus low, medium, and Article Title: Improving Specificity for Ovarian Cancer Screening Using a Novel Extracellular Vesicle–Based Blood Test Article Snippet: The VarioSkan Lux (catalog number VL0000D0; Thermo Fisher Scientific, Waltham, MA) was used to measure the resultant OD of the plate at 450, 540, and 570 nm. .. Blinded human plasma and serum samples as well as Lyphochek Tumor Marker Plus low, medium, and Control:Article Title: Improving specificity for ovarian cancer screening using a novel extracellular vesicle-based blood test - Performance in a training and verification cohort. Article Snippet: The VarioSkan Lux (catalog number VL0000D0; Thermo Fisher Scientific, Waltham, MA) was used to measure the resultant OD of the plate at 450, 540, and 570 nm. .. Blinded human plasma and serum samples as well as Lyphochek Tumor Marker Plus low, medium, and Article Title: Improving Specificity for Ovarian Cancer Screening Using a Novel Extracellular Vesicle–Based Blood Test Article Snippet: The VarioSkan Lux (catalog number VL0000D0; Thermo Fisher Scientific, Waltham, MA) was used to measure the resultant OD of the plate at 450, 540, and 570 nm. .. Blinded human plasma and serum samples as well as Lyphochek Tumor Marker Plus low, medium, and Saline:Article Title: Improving specificity for ovarian cancer screening using a novel extracellular vesicle-based blood test - Performance in a training and verification cohort. Article Snippet: The VarioSkan Lux (catalog number VL0000D0; Thermo Fisher Scientific, Waltham, MA) was used to measure the resultant OD of the plate at 450, 540, and 570 nm. .. Blinded human plasma and serum samples as well as Lyphochek Tumor Marker Plus low, medium, and Article Title: Improving Specificity for Ovarian Cancer Screening Using a Novel Extracellular Vesicle–Based Blood Test Article Snippet: The VarioSkan Lux (catalog number VL0000D0; Thermo Fisher Scientific, Waltham, MA) was used to measure the resultant OD of the plate at 450, 540, and 570 nm. .. Blinded human plasma and serum samples as well as Lyphochek Tumor Marker Plus low, medium, and |